U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C18H22BrNO3
Molecular Weight 380.276
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CIMBI-36

SMILES

COC1=CC=CC=C1CNCCC2=CC(OC)=C(Br)C=C2OC

InChI

InChIKey=SUXGNJVVBGJEFB-UHFFFAOYSA-N
InChI=1S/C18H22BrNO3/c1-21-16-7-5-4-6-14(16)12-20-9-8-13-10-18(23-3)15(19)11-17(13)22-2/h4-7,10-11,20H,8-9,12H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C18H22BrNO3
Molecular Weight 380.276
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Mon Mar 31 23:42:27 GMT 2025
Edited
by admin
on Mon Mar 31 23:42:27 GMT 2025
Record UNII
S6NAA81PHK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CIMBI-36
Common Name English
25B-NBOME
Preferred Name English
4-BROMO-2,5-DIMETHOXY-N-(2-METHOXYBENZYL)PHENETHYLAMINE
Systematic Name English
BENZENEETHANAMINE, 4-BROMO-2,5-DIMETHOXY-N-((2-METHOXYPHENYL)METHYL)-
Systematic Name English
2,5-DIMETHOXY-4-BROMO-N-(2-METHOXYBENZYL)PHENETHYLAMINE
Systematic Name English
2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL)ETHANAMINE
Systematic Name English
Classification Tree Code System Code
DEA NO. 7536
Created by admin on Mon Mar 31 23:42:27 GMT 2025 , Edited by admin on Mon Mar 31 23:42:27 GMT 2025
WIKIPEDIA Designer-drugs-25B-NBOMe
Created by admin on Mon Mar 31 23:42:27 GMT 2025 , Edited by admin on Mon Mar 31 23:42:27 GMT 2025
Code System Code Type Description
PUBCHEM
9977044
Created by admin on Mon Mar 31 23:42:27 GMT 2025 , Edited by admin on Mon Mar 31 23:42:27 GMT 2025
PRIMARY
EPA CompTox
DTXSID50907974
Created by admin on Mon Mar 31 23:42:27 GMT 2025 , Edited by admin on Mon Mar 31 23:42:27 GMT 2025
PRIMARY
CAS
1026511-90-9
Created by admin on Mon Mar 31 23:42:27 GMT 2025 , Edited by admin on Mon Mar 31 23:42:27 GMT 2025
PRIMARY
FDA UNII
S6NAA81PHK
Created by admin on Mon Mar 31 23:42:27 GMT 2025 , Edited by admin on Mon Mar 31 23:42:27 GMT 2025
PRIMARY
WIKIPEDIA
25B-NBOMe
Created by admin on Mon Mar 31 23:42:27 GMT 2025 , Edited by admin on Mon Mar 31 23:42:27 GMT 2025
PRIMARY 25B-NBOMe (NBOMe-2C-B, Cimbi-36, Nova, BOM 2-CB) is a derivative of the phenethylamine psychedelic 2C-B, discovered in 2004 by Ralf Heim at the Free University of Berlin. It acts as a potent partial agonist for the 5HT2A receptor. Anecdotal reports from users(citation needed) suggest 25B-NBOMe to be an active hallucinogen at a dose of as little as 250500 undefinedg,(citation needed) making it a similar potency to other phenethylamine derived hallucinogens such as bromo-dragonfly. Duration of effects lasts about 1216 hours.
Related Record Type Details
TARGET -> AGONIST
Ki
LABELED -> NON-LABELED
SALT/SOLVATE -> PARENT
TARGET -> AGONIST
Ki
Related Record Type Details
ACTIVE MOIETY